Skip to main content
. 2018 Apr 27;3:11. doi: 10.1038/s41525-018-0050-y

Fig. 1.

Fig. 1

Proportions of result outcomes among the total cohort, and by NGS panel group. BCP breast cancer panel, MCP multi-cancer panel, PV pathogenic variant detected, PV + VUS pathogenic variant and variant of uncertain significance detected, VUS variant of uncertain significance detected; Negative, no variants (PV or VUS) detected